Modification of nitric oxide synthase activity and neuronal response in rat striatum by melatonin and kynurenine derivatives

Journal of Neuroendocrinology

Volumn 10, Issue 4, 1998, Pages 297-302

  León, Josefa ^a   Vives, Francisco ^a   Crespo, Elena ^a   Camacho, Encarnación ^b   Espinosa, Antonio ^b   Gallo, Miguel A ^b   Escames, Germaine ^a   Acuña Castroviejo, Darío ^a,c  

^a UNIVERSITY OF GRANADA   (Spain)

^b UNIVERSITY OF GRANADA   (Spain)

^c UNIVERSITY OF GRANADA   (Spain)

Author keywords

Kynurenine derivatives; Melatonin; Nitric oxide; Nitric oxide synthase; Striatum

Indexed keywords

BRAIN ENZYME; BUTYRIC ACID DERIVATIVE; GLUTAMIC ACID; KYNURENINE; MELATONIN; NITRIC OXIDE SYNTHASE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN DEPTH STIMULATION; BRAIN NERVE CELL; CONTROLLED STUDY; CORPUS STRIATUM; ENZYME ACTIVITY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SENSORIMOTOR CORTEX; STRUCTURE ACTIVITY RELATION;

ANIMALS; CORPUS STRIATUM; ELECTRIC STIMULATION; GLUTAMIC ACID; KYNURENINE; MELATONIN; NEURONS; NITRIC OXIDE SYNTHASE; RATS; SOMATOSENSORY CORTEX;

EID: 0031976485     PISSN: 09538194     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2826.1998.00203.x     Document Type: Article

References (38)

1. Herrling PL. Clinical implications of NMDA receptors. In: Collindridge, GL, Watkins JC, eds. The NMDA Receptor, Oxford: Oxford University Press, 1994: 376-394.
2. Blandini F, Porter RHP, Greenamyre JT. Glutamate and Parkinson's disease. Mol Neurobiol 1996; 12: 73-94.
3. Moncada S, Palmer RMJ, Higgs EA. Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol Rev 1991; 43: 109-134.
4. Garthwaite J. Glutamate, nitric oxide and cell-signalling in the nervous system. TINS 1991; 14: 60-67.
5. Rusak B, Yu GD. Regulatin of melatonin-sensitive and firing-rate rhythms of hamster suprachiasmatic nucleus neurons: Pinealectomy effects. Brain Res 1993; 602: 200-204.
6. Acuña-Castroviejo D, Escames G, Macias M, Muñoz-Hoyos A, Molina-Carballo A, Arauzo M, Montes R, Vives F. Cell protective role of melatonin in the brain. J Pineal Res 1995; 19: 57-63.
7. 2+ epileptiform activity in human temporal slices. Exp Brain Res 1995; 107: 321-325.
8. Albertson TE, Peterson SL, Stark LG, Lakin ML, Winters WD. The anticonvulsant properties of melatonin on kindled seizures in rats. Neuropharmacology 1981; 20: 61-66.
9. Golombek DA, Fernandez-Duque D, De Brito-Sanchez MG, Burin L, Cardinali DP. Time-dependent anticonvulsant activity of melatonin in hamsters. Eur J Pharmacol 1992; 210: 253-258.
10. Golombek DA, Rosenstein RE, Cardinali DP. Benzodiazepine antagonism abolishes melatonin effects on rodent behavior. In: Touitou Y, Arendt J, Pevet P, eds. Melatonin and the Pineal Gland. From Basic Science to Clinical Application, Amsterdam: Excerpta Medica, 1993; 255-260.
11. Champney TH, Peterson SL. Circadian, seasonal, pineal, and melatonin influences on epilepsy. In: Yu HS, Reiter RJ, eds. Melatonin. Biosynthesis, Physiological Effects, and Clinical Applications, Boca Raton: CRC Press, 1993: 477-494.
12. Cardinali DP, Golombek DA, Rosenstein RE, Kanterewicz BA, Fiszman M. Chronobiological activity of melatonin: mediation by GABAergic mechanism. In: Fraschini F, Reiter RJ, Stankov B, eds. The Pineal Gland and its Hormones. Fundamentals and Clinical Perspectives, New York: Plenum Press, 1995: 119-130.
13. Anton-Tay F. Melatonin: effects on brain function. Adv Biochem Psychopharmacol 1974; 11: 315-324.
14. Acuña-Castroviejo D, Coto-Montes A, Monti MG, Ortiz GG, Reiter RJ. Melatonin is protective against MPTP-induced striatal and hippocampal lesions. Life Sci 1997; 60: 23-29.
15. Molina-Carballo A, Muñoz-Hoyos A, Reiter RJ, Sánchez-Forte M, Moreno-Madrid F, Rufo-Campos M, Molina-Font JA, Acuña-Castroviejo D. Utility of high doses of melatonin as adjunctive anticonvulsant therapy in a child with severe myoclonic epilepsy: two years' experience. J Pineal Res 1997; 23: 97-105.
16. Escames G, Acuña-Castroviejo D, Vives F. Melatonin-dopamine interaction in the striatal projection area of sensorimotor cortex in the rat. Neuro Report 1996; 7: 597-600.
17. Reiter RJ, Melchiorri D, Sewerinek E, Poeggeler B, Barlow-Walden L, Chuang J, Ortiz GG, Acuña-Castroviejo D. A review of the evidence supporting melatonin's role as an antioxidant. J Pineal Res 1995; 18: 1-11.
18. Pozo D, Reiter RJ, Calvo JR, Guerrero JM. Physiological concentrations of melatonin inhibit nitric oxide synthase in rat cerebellum. Life Sci 1994; 55: 455-460.
19. Bettahi I, Pozo D, Osuna C, Reiter RJ, Acuña-Castroviejo D, Guerrero J. Melatonin reduces nitric oxide synthase activity in rat hipothalamus. J Pineal Res 1996; 20: 205-210.
20. Pozo D, Reiter RJ, Calvo JR, Guerrero JM. Inhibition of cerebellar nitric oxide synthase and cyclic GMP production by melatonin via complex formation with calmodulin. J Cell Biochem 1997; 65: 430-442.
21. Uz T, Giusti P, Franceschini D, Kharlamov A, Manev H. Protective effect of melatonin against hippocampal DNA damage induced by intraperitoneal administration of kainate to rats. Neuroscience 1996; 73: 631-636.
22. Giusti P, Lipartiti M, Franceschini D, Schiavo N, Floreani M. Manev H. Neuroprotection by melatonin from kainate-induced excitotoxicity in rats. FASEB J 1996; 10: 891-896.
23. Giusti P, Gusella M, Lipartiti M, Milani D, Zhu W, Vicini S, Manev H. Melatonin protects primary cultures of cerebellar granule neurons from kainate but not from N-Methyl-D-aspartate excitotoxicity. Exp Neurol 1995; 131: 39-46.
24. Swartz KJ, During MJ, Freese A, Beal MF. Cerebral synthesis and release of kynurenic acid: an endogenous antagonist of excitatory amino acid receptors. J Neurosci 1990; 10: 2965-2973.
25. Schwarcz R. Metabolism and function of brain kynurenines. Biochem Soc Trans 1993; 21: 77-82.
26. Hirata F, Hayaishi O, Tokuyama T, Senoh S. In vitro and in vivo formation of two new metabolites of melatonin. J Biol Chem 1974; 249: 1311-1313.
27. Reiter RJ. Pineal melatonin: cell biology of its synthesis and of its physiological interactions. Endocr Rev 1991; 12: 151-180.
28. Menéndez-Pelaez A, Poeggeler B, Reiter RJ, Barlow-Walden L, Pablos MI, Tan DX. Nuclear localization of melatonin in different mammalian tissues: immunocytochemical and radioimmunoassay evidence. J Cell Biochem 1993; 54: 1-10.
29. Castillo-Romero JL, Vives-Montero F, Reiter RJ, Acuña-Castroviejo D. Pineal modulation of the rat caudate-putamen spontaneous neuronal activity: roles of melatonin and vasotocin. J Pineal Res 1993; 15: 147-152.
30. Castillo-Romero JL, Acuña-Castroviejo D, Escames G, Vives F. Age-related changes of neuronal responsiveness to melatonin in the striatum of sham-operated and pinealectomized rats. J Pineal Res 1995; 19:79-86.
31. Pelliciari R, Natalini B, Costantino G, Mahmoud MR, Mattoli L. Sadeghpour BN. Modulation of the kynurenine pathway in search for new neuroprotective agents. Synthesis and preliminary evaluation of (m-nitrobenzoyl) alanine, a potent inhibitor of kynurenine-3-hydroxylase. J Med Chem 1994; 37: 647-655.
32. Kennaway DJ, Hugel HM. Melatonin, melatonin metabolites and the suprachiasmatic nucleus In: Foldes A, Reiter RJ, eds. Advances in Pineal Research. Vol. 6. London: John Libbey, 1991: 169-178.
33. Muñoz-Hoyos A, Molina-Carballo A, Rodríguez-Cabezas T, Uberos-Fernández J, Ruiz-Cosano C, Acuña-Castroviejo D. Relationships between methoxyindole and kynurenine pathway metabolites in plasma and urine in children suffering from febrile and epileptic seizures. Clin Endocrinol 1997; 00: 000-000.
34. Kamisaki Y, Wada K, Nakamoto K, Itoh T. Nitric oxide inhibition of the depolarization-evoked glutamate release from synaptosomes of rat cerebellum. Neurosci Lett 1995; 194: 5-8.
35. Calabresi P, Mercuri NB, Bernardi G. Chemical modulation of synaptic transmission in the striatum. In: Arbuthnott GW, Emson PC, eds. Chemical Signalling in the Basal Ganglia, Amsterdam: Elsevier, 1993: 299-308.
36. Chuang JI, Ling MT. Pharmacological effects of melatonin treatment on both locomotor activity and brain serotonin release in rats. J Pineal Res 1994; 17: 11-16.
37. Manzoni O, Bockaert J. Nitric oxide synthase activity endogenously modulates NMDA receptors. J Neurochem 1993; 61: 368-370.
38. Bredt DS, Snyder SH. Isolation of nitric oxyde synthetase, a calmodulinrequiring enzyme. Proc Natl Acad Sci USA 1990; 87: 682-685.